Published in Ann Surg on January 01, 1999
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol (2009) 1.94
Merkel cell carcinoma. World J Surg Oncol (2006) 1.33
Impact of sentinel lymph node biopsy in patients with Merkel cell carcinoma: results of a prospective study and review of the literature. Eur J Nucl Med Mol Imaging (2006) 1.03
A practical update of surgical management of merkel cell carcinoma of the skin. ISRN Surg (2013) 0.89
A review of the epidemiology and treatment of Merkel cell carcinoma. Clinics (Sao Paulo) (2011) 0.89
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer (2013) 0.86
Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status. Hum Pathol (2010) 0.84
Merkel cell carcinoma. Am J Clin Oncol (2013) 0.83
Milestones in the staging, classification, and biology of Merkel cell carcinoma. J Natl Compr Canc Netw (2014) 0.82
Ileocaecal recurrence of Merkel cell carcinoma of the skin: a case report. J Med Case Rep (2010) 0.81
Merkel cell polyomavirus and extrapulmonary small cell carcinoma. Oncol Lett (2013) 0.80
Merkel cell carcinoma of skin-current controversies and recommendations. Rare Tumors (2011) 0.80
Digital Merkel cell carcinoma. Can J Plast Surg (2005) 0.79
The role of free tissue transfer in merkel cell carcinoma of the head and neck. J Skin Cancer (2012) 0.79
Cerebral metastases from Merkel cell carcinoma: long-term survival. J Surg Case Rep (2016) 0.77
Oropharyngeal metastasis of a Merkel cell carcinoma of the skin. Eur Arch Otorhinolaryngol (2002) 0.76
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients. Mod Pathol (2015) 0.75
Focus on Merkel cell carcinoma: diagnosis and staging. Skeletal Radiol (2015) 0.75
Immunohistochemical and ultrastructural investigation on cutaneous neuroendocrine carcinoma: report of a case and review of the literature. Med Mol Morphol (2006) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Trabecular carcinoma of the skin. Arch Dermatol (1972) 3.66
Trabecular carcinoma of the skin: an ultrastructural study. Cancer (1978) 1.75
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Is aggressive surgical management justified in the treatment of Merkel cell carcinoma? Plast Reconstr Surg (1994) 1.54
Merkel cell tumour: clinical behaviour and treatment. Br J Surg (1991) 1.50
Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg (1988) 1.34
Neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias, and neoplasms. Lab Invest (1985) 1.33
Merkel cell carcinoma. J Am Acad Dermatol (1993) 1.26
The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys (1995) 1.17
Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease. Cancer (1986) 1.14
Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol (1997) 1.12
An analysis of prognostic factors in cutaneous neuroendocrine carcinoma. Laryngoscope (1992) 0.95
Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys (1995) 0.94
Cutaneous neuroendocrine (Merkel cell) carcinoma. A report of 35 cases. Am J Clin Oncol (1995) 0.91
Merkel cell tumor. A chemosensitive skin cancer. Cancer (1988) 0.91
Clinicopathologic correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol (1988) 0.90
Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature. Am J Clin Oncol (1991) 0.88
Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience. Cancer (1988) 0.86
Merkel cell carcinoma: management of primary, recurrent and metastatic disease. A clinicopathological study of 17 patients. Eur J Surg Oncol (1989) 0.83
VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission. Am J Clin Oncol (1993) 0.83
Chemotherapy of metastatic Merkel cell cancer. Cancer Invest (1991) 0.81
Lymphoscintigraphy in a case of Merkel cell tumor. Clin Nucl Med (1995) 0.80
Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol (1995) 0.79
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
Tensile ductility and necking of metallic glass. Nat Mater (2007) 2.90
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74
Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 2.61
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst (1998) 2.39
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol (1999) 2.38
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Primitive deuterostomes from the Chengjiang Lagerstätte (Lower Cambrian, China). Nature (2001) 2.31
Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiol Biomarkers Prev (1994) 2.26
Deletion of the p16 and p15 genes in human bladder tumors. J Natl Cancer Inst (1995) 2.25
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol (1997) 2.13
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97
Cystectomy for bladder cancer: a contemporary series. J Urol (2001) 1.85
A new species of yunnanozoan with implications for deuterostome evolution. Science (2003) 1.82
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up. J Clin Oncol (1994) 1.78
Male urethral carcinoma: analysis of treatment outcome. Urology (1999) 1.77
Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev (2000) 1.76
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial. J Clin Oncol (1995) 1.71
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol (1995) 1.70
Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol (2000) 1.58
p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer (1994) 1.58
Altered patterns of MDM2 and TP53 expression in human bladder cancer. J Natl Cancer Inst (1994) 1.52
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46
Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45
Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol (1999) 1.44
Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer (2001) 1.43
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst (1993) 1.42
Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev (1997) 1.40
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res (1997) 1.35
Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann Surg Oncol (1998) 1.35
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China. Diabetologia (2009) 1.34
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. Urology (1996) 1.32
Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer (1997) 1.31
Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res (1995) 1.29
Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci U S A (1990) 1.28
GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev (2000) 1.26
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol (1995) 1.26
Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol (1999) 1.26
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancer. J Natl Cancer Inst (1999) 1.25
Melanoma metastatic to stomach, small bowel, or colon. Am J Surg (1991) 1.24
Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol (2001) 1.24
p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients. J Clin Oncol (1994) 1.22
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab (1996) 1.22
Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia (2008) 1.19
The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer (1997) 1.17
Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. Am J Epidemiol (1995) 1.16
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Gastric cardia cancer and dietary fiber. Gastroenterology (2001) 1.10
Bis(thiosemicarbazide-S,N)zinc(II) dinitrate. Acta Crystallogr C (2000) 1.10
Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J Urol (1994) 1.10
Alcohol drinking, body mass index and the risk of oral leukoplakia in an Indian population. Int J Cancer (2000) 1.09
Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol (1996) 1.08
Socioeconomic status, lifestyle factors and oral premalignant lesions. Oral Oncol (2003) 1.08
Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.06
p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol (1998) 1.05
Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade. Neuroscience (2009) 1.05
Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.04
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer (2011) 1.01
Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J Urol (1994) 1.01
Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res (1998) 1.01
Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00
Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol (1996) 1.00
Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg (1999) 0.98
Hexakis(antipyrine-O)terbium(III) triperchlorate. Acta Crystallogr C (2000) 0.97
Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96
Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer (2001) 0.95
Isolation and characterization of the gene and cDNA encoding human mitochondrial creatine kinase. J Biol Chem (1989) 0.95
Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity. Laryngoscope (1997) 0.94
Major amputation for advanced malignant melanoma. Surg Gynecol Obstet (1989) 0.94
High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br J Cancer (1994) 0.94
Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res (1998) 0.94
First report of the emergence of New Delhi metallo-β-lactamase-1 producing Acinetobacter junii in Nanjing, China. Indian J Med Microbiol (2013) 0.93
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol (2006) 0.93
Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst (1999) 0.93
Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J Urol (1994) 0.93
Optimizing the tensile properties of polyvinyl alcohol hydrogel for the construction of a bioprosthetic heart valve stent. J Biomed Mater Res (2002) 0.92
Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol (2000) 0.91
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910). J Int Med Res (2009) 0.91
GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control (2001) 0.91
Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology (1997) 0.89
Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome. J Clin Oncol (1996) 0.88
The impact of ejaculation on serum prostate specific antigen. J Urol (1993) 0.88
Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg (1992) 0.86